Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Scheduled Weekly Sms Reminder Of Health Facility Ri Schedule To Community Leaders

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT04001322Not ApplicableCompletedPrimary

Tunatar da ni. The Immunization Reminder and Information SMS System (IRISS)

Showing all 1 trials

Research Network

Common Treatments

  • Scheduled Weekly Sms Reminder Of Health Facility Ri Schedule To Community Leaders1
  • Scheduled Bi Weekly Ri Messages To Community Leaders1
  • Onetime Sms Broadcast On Immunization1
  • Responsive Individualized Child Vaccination Schedule Reminder To Caregivers Who Optin1
  • Responsive Onetime Sms Message On Hand Washing To Those That Erroneously Register On Iriss1

Active Sponsors

  • Bill and Melinda Gates Foundation1
  • Direct Consulting and Logistics1
  • Johns Hopkins Bloomberg School of Public Health1

Top Investigators

Activity Timeline